FIELD: medicine; pharmacology.
SUBSTANCE: essence of the invention includes an agent for external application which structure includes a peptide from the allopherones group, allostatin-1 and auxiliary substances. The offered agent is applied to treatment of diseases of a skin and mucosa caused by a virus of herpes, a virus of papilloma, and also cosmetic defects of a skin.
EFFECT: scope expansion.
4 cl, 1 dwg, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR EXTERNAL USE WITH ANTIVIRAL ACTION | 2021 |
|
RU2819719C2 |
| ANTI-TUMOR AND ANTIVIRAL PEPTIDES | 2004 |
|
RU2267496C2 |
| BIOLOGICALLY ACTIVE PEPTIDES | 2013 |
|
RU2575069C2 |
| AGENT POSSESSING BIOCIDAL ACTION | 2017 |
|
RU2673807C2 |
| METHOD FOR ACTIVATION OF CYTOTOXIC LYMPHOCYTES | 2019 |
|
RU2751837C2 |
| ALLOPHERONES AS IMMUNOMODULATING PEPTIDES | 1999 |
|
RU2172322C1 |
| METHOD OF PRODUCING A DRUG BASED ON OLIGOPEPTIDE ALLOFERON-1, HAVING AN ANTIVIRAL AND IMMUNOMODULATING EFFECT, AND PROLONGED STORAGE MEDICINAL PRODUCT OBTAINED WITH ITS HELP | 2017 |
|
RU2737852C2 |
| COMPOSITION FOR ELIMINATION OF HERPETIC ERUPTIONS SYMPTOMS | 2022 |
|
RU2796727C1 |
| BIOLOGICALLY ACTIVE DERIVATIVES OF ALLOFERON-1 | 2013 |
|
RU2576830C2 |
| ANTIVIRAL PREPARATION FOR EXTERNAL APPLICATION BASED UPON HYALURONIC ACID | 1999 |
|
RU2178693C2 |
